Skip to main content

HTG Molecular Diagnostics, Inc

HTGMDelisted Jul 10, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001169987

HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in HTG Molecular Diagnostics, Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
22
0 vs. Q1 2022
Shares held
606.0K
−1.69M (−73.6%) vs. Q1 2022
Total value
$622.0K
−$2.57M (−80.5%) vs. Q1 2022
New holders
4
7 more added
Sold out
4
4 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 22 institutions
Q1 2021: 23 institutionsQ2 2021: 25 institutionsQ3 2021: 23 institutionsQ4 2021: 23 institutionsQ1 2022: 22 institutionsQ2 2022: 22 institutionsQ3 2022: 19 institutionsQ4 2022: 10 institutionsQ1 2023: 12 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $622.0K
Q1 2021: $11.2MQ2 2021: $19.7MQ3 2021: $16.4MQ4 2021: $14.5MQ1 2022: $3.19MQ2 2022: $622.0KQ3 2022: $283.0KQ4 2022: $66.2KQ1 2023: $67.3KQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding HTGM and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 202312$67.3K
Q4 202210$66.2K
Q3 202219$283.0K
Q2 202222$622.0K
Q1 202222$3.19M
Q4 202123$14.5M
Q3 202123$16.4M
Q2 202125$19.7M
Q1 202123$11.2M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q1 2022.

Institutions holding HTGM in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC154,038$159.0K0.00%+98,522+177.5%Added
Susquehanna International Group, LLP99,054$102.0K0.00%+99,054New
Vanguard Group Inc75,417$78.0K0.00%−170,349−69.3%Reduced
BlackRock Inc.75,914$78.0K0.00%+60,103+380.1%Added
Two Sigma Securities, LLC57,454$59.0K0.01%+57,454New
Geode Capital Management, LLC47,178$48.0K0.00%+1,139+2.5%Added
Millennium Management LLC22,615$23.0K0.00%−4,877−17.7%Reduced
Citigroup Inc20,625$21.0K0.00%+17,625+587.5%Added
State Street Corp14,455$15.0K0.00%00.0%Unchanged
Virtu Financial LLC13,127$14.0K0.00%+13,127New
Morgan Stanley10,023$10.0K0.00%−4,740−32.1%Reduced
HighMark Wealth Management LLC6,966$7.00K0.01%00.0%Unchanged
Tower Research Capital LLC (TRC)5,156$5.00K0.00%+3,891+307.6%Added
Allworth Financial LP3,327$3.00K0.00%00.0%Unchanged
UBS Group AG26$00.00%−3,974−99.4%Reduced
JPMorgan Chase & Co387$00.00%+50+14.8%Added
Wells Fargo & Company50$00.00%+9+22.0%Added
1832 Asset Management L.P.66$00.00%00.0%Unchanged
TCI Wealth Advisors, Inc.26$00.00%00.0%Unchanged
Surevest, LLC1$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.13$00.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co60$00.00%+60New
Armistice Capital, LLC0$00.00%−834,054−100.0%Sold out
Samjo Capital LLC0$00.00%−404,963−100.0%Sold out
Cowen Prime Advisors LLC0$00.00%−332,197−100.0%Sold out
Nantahala Capital Management, LLC0$00.00%−285,963−100.0%Sold out